Literature DB >> 19554648

Systemic abnormalities in liver disease.

Masami Minemura, Kazuto Tajiri, Yukihiro Shimizu.   

Abstract

Systemic abnormalities often occur in patients with liver disease. In particular, cardiopulmonary or renal diseases accompanied by advanced liver disease can be serious and may determine the quality of life and prognosis of patients. Therefore, both hepatologists and non-hepatologists should pay attention to such abnormalities in the management of patients with liver diseases.

Entities:  

Mesh：

Year:  2009        PMID： 19554648      PMCID： PMC2702103          DOI： 10.3748/wjg.15.2960

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  218 in total

1.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation.

Authors:  S E Battaglia; J J Pretto; L B Irving; R M Jones; P W Angus
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

3.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.

Authors:  P Amodio; F Del Piccolo; P Marchetti; P Angeli; R Iemmolo; L Caregaro; C Merkel; G Gerunda; A Gatta
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

6.  Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Authors:  Annette Bruchfeld; Karin Lindahl; Lars Ståhle; Magnus Söderberg; Robert Schvarcz
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

7.  Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis.

Authors:  Sachin Mathur; Szelin Peng; Edward J Gane; John L McCall; Lindsay D Plank
Journal:  Nutrition       Date:  2007-03-29       Impact factor: 4.008

8.  Erectile dysfunction in end-stage liver disease men.

Authors:  Eric Huyghe; Nassim Kamar; Fabien Wagner; Aude-Hélène Capietto; Labib El-Kahwaji; Fabrice Muscari; Pierre Plante; Lionel Rostaing
Journal:  J Sex Med       Date:  2009-02-04       Impact factor: 3.802

Review 9.  Extrahepatic manifestations of hepatitis C virus.

Authors:  Richard K Sterling; S Bralow
Journal:  Curr Gastroenterol Rep       Date:  2006-02

10.  Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.

Authors:  Amitabh Suman; David S Barnes; Nizar N Zein; Gavin N Levinthal; Jason T Connor; William D Carey
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382
View more
  10 in total

Review 1.  Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis.

Authors:  Pei-Jing Cui; Jing Yao; Yi-Jun Zhao; Hua-Zhong Han; Jun Yang
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 2.  Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases.

Authors:  Mrigya Babuta; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2021-11-10       Impact factor: 6.011

3.  Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study.

Authors:  Hany M Abo-Haded; Tarik S Barakat; Mona M Hafez
Journal:  Eur J Pediatr       Date:  2013-06-29       Impact factor: 3.183

Review 4.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

5.  Roles of Simvastatin and Sildenafil in Modulation of Cranial Irradiation-Induced Bystander Multiple Organs Injury in Rats.

Authors:  Engy Refaat Rashed; Mohamed Khairy Abdel-Rafei; Noura Magdy Thabet
Journal:  Inflammation       Date:  2021-08-21       Impact factor: 4.092

Review 6.  Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.

Authors:  Gonçalo S Clemente; Aren van Waarde; Inês F Antunes; Alexander Dömling; Philip H Elsinga
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

7.  Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?

Authors:  Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Journal:  J Clin Med       Date:  2022-02-04       Impact factor: 4.241

Review 8.  Unraveling the Complexity of Liver Disease One Cell at a Time.

Authors:  Gary D Bader; Ian D McGilvray; Sonya A MacParland; Jawairia Atif; Cornelia Thoeni
Journal:  Semin Liver Dis       Date:  2022-08-25       Impact factor: 6.512

9.  Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats.

Authors:  Venkat R Pannala; Shanea K Estes; Mohsin Rahim; Irina Trenary; Tracy P O'Brien; Chiyo Shiota; Richard L Printz; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

Review 10.  Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract.

Authors:  Marek Droździk; Stefan Oswald; Agnieszka Droździk
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.